Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A35252 | 21291347 | Expert Opin Ther Targets | Targets of chymase inhibitors. | 2011 | Details |
A35331 | 21072894 | World J Gastroenterol | Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates. | 2010 | Details |
A35342 | 21046243 | Dig Dis Sci | Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. | 2010 | Details |
A35636 | 22798443 | BMJ Case Rep | A hot, swollen joint in a cirrhotic patient. | 2010 | Details |
A35905 | 19450760 | Biol Blood Marrow Transplant | Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study. | 2009 | Details |
A36345 | 18397235 | Liver Int | Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. | 2008 | Details |
A36384 | 18328071 | Hepatol Res | Prevalence of esophagogastric varices in patients with non-alcoholic steatohepatitis. | 2008 | Details |
A36449 | 18186574 | World J Gastroenterol | Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. | 2008 | Details |
A36464 | 18090988 | Eur J Gastroenterol Hepatol | Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases. | 2008 | Details |
A36852 | 17085338 | Hepatobiliary Pancreat Dis Int | Cisapride decreasing orocecal transit time in patients with nonalcoholic steatohepatitis. | 2006 | Details |
A36914 | 16952548 | Gastroenterology | Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. | 2006 | Details |
A36999 | 16768106 | Nihon Rinsho | [Hepatocyte-specific Pten deficient mice]. | 2006 | Details |
A37019 | 16706830 | J Gastroenterol Hepatol | Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. | 2006 | Details |
A37430 | 15703559 | Curr Opin Gastroenterol | Hepatobiliary pathology. | 2003 | Details |
A37605 | 15298631 | Aliment Pharmacol Ther | Personal view: 'don't ask, don't tell'--the undesirable consequences of incidental test results in gastroenterology. | 2004 | Details |
A37611 | 15277442 | Diabetes Care | Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. | 2004 | Details |
A37639 | 15220676 | J Clin Gastroenterol | Probiotics: a potential target for the prevention and treatment of steatohepatitis. | 2004 | Details |
A37945 | 12709080 | Clin Transplant | Renal transplant recipient attitudes toward steroid use and steroid withdrawal. | 2003 | Details |
A38208 | 11897208 | Am J Cardiol | Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. | 2002 | Details |
A38236 | 11812920 | Toxicol Sci | Mechanisms of hepatotoxicity. | 2002 | Details |
A38386 | 11380417 | Br J Haematol | A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest. | 2001 | Details |
A38407 | 11316170 | Am J Gastroenterol | Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. | 2001 | Details |
A38709 | 10515698 | Carbohydr Res | Polyhydroxylated pyrrolidine and pyrrolizidine alkaloids from Hyancinthoides non-scripta and Scilla campanulata. | 1999 | Details |
A38853 | 9770618 | Int J Parasitol | Molecular comparison of Giardia lamblia isolates. | 1998 | Details |
A39214 | 8675165 | Hepatology | Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. | 1996 | Details |
A39495 | 8049447 | Blood | Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. | 1994 | Details |
A39508 | 7922096 | Br J Surg | Predictors of upper gastrointestinal bleeding in patients with schistosomal periportal fibrosis. | 1994 | Details |
A39691 | 8093887 | J Cell Biol | Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion. | 1993 | Details |
A39799 | 1577855 | J Cell Biol | Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways. | 1992 | Details |
A39887 | 1928571 | Am J Trop Med Hyg | Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. | 1991 | Details |
A39900 | 1831006 | Am J Med | Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. | 1991 | Details |
A40077 | 2159232 | Am J Physiol | Identification of a 50-kDa Ca-, cAMP-, and cGMP-dependent epithelial phosphoprotein as a cAMP regulatory protein. | 1990 | Details |
A40080 | 2340390 | Br J Surg | Epidermal growth factor increases tensile strength in intestinal wounds in pigs. | 1990 | Details |
A40949 | 6174609 | J Immunol | Factors that modulate clearance and ultimate fate of a specific schistosome antigen (GASP) in schistosome infections. | 1982 | Details |
A42226 | 35169106 | Am J Gastroenterol | Evolutionary medicine perspectives: H. pylori, lactose intolerance, and three hypotheses for functional and inflammatory gastrointestinal and hepatobiliary disorders. | 2022 | Details |
A42229 | 35165436 | Nat Rev Gastroenterol Hepatol | Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. | 2022 | Details |
A42258 | 35066086 | J Hepatol | A disease-promoting role of the intestinal mycobiome in non-alcoholic fatty liver disease. | 2022 | Details |
A42277 | 35017674 | Nat Rev Gastroenterol Hepatol | Distinct faecal mycobiome in patients with NAFLD. | 2022 | Details |
A42289 | 34964947 | J Microbiol | The human symbiont Bacteroides thetaiotaomicron promotes diet-induced obesity by regulating host lipid metabolism. | 2021 | Details |
A42308 | 34912328 | Front Immunol | Fecal Microbiota Transplantation Controls Progression of Experimental Autoimmune Hepatitis in Mice by Modulating the TFR/TFH Immune Imbalance and Intestinal Microbiota Composition. | 2021 | Details |
A42327 | 34855340 | FP Essent | Liver Disease: Cirrhosis. | 2021 | Details |
A42367 | 34753791 | J Clin Pathol | Improved pathology reporting in NAFLD/NASH for clinical trials. | 2021 | Details |
A42370 | 34741331 | Aliment Pharmacol Ther | Letter: cross-linkage between bacterial taxonomy and gene functions-a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease. | 2021 | Details |
A42388 | 34698580 | Crit Rev Food Sci Nutr | Effect of kombucha intake on the gut microbiota and obesity-related comorbidities: A systematic review. | 2021 | Details |
A42396 | 34674606 | Gut Microbes | Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases? | 2022 | Details |
A42409 | 34616249 | Case Rep Gastroenterol | Upper GI Bleeding Secondary to Radiation Gastritis in a Patient with Preexisting Portal Hypertensive Gastropathy. | 2021 | Details |
A42412 | 34603218 | Front Endocrinol (Lausanne) | Editorial: The Brain - Gut - Microbiome Network in Metabolic Regulation and Dysregulation. | 2021 | Details |
A42481 | 34422393 | J Gastrointest Oncol | A discussion of the gut microbiome's development, determinants, and dysbiosis in cancers of the esophagus and stomach. | 2021 | Details |
A42511 | 34328191 | Int J Mol Med | Dysbiosis and liver diseases (Review). | 2021 | Details |
A42518 | 34305616 | Front Pharmacol | Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. | 2021 | Details |
A42538 | 34220702 | Front Endocrinol (Lausanne) | Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders? | 2021 | Details |
A42593 | 34080232 | Immunol Cell Biol | Zone defence - the gut microbiota position macrophages for optimal liver protection. | 2021 | Details |
A42632 | 33960005 | Hepatology | The Glucagon-Like Peptide-1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis. | 2021 | Details |
A42638 | 33933727 | Clin Nutr | Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adults. | 2021 | Details |
A42740 | 33599321 | Aliment Pharmacol Ther | Editorial: metagenome-assembled genomes in non-alcoholic fatty liver disease. | 2021 | Details |
A42755 | 33568795 | Nat Rev Gastroenterol Hepatol | The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. | 2021 | Details |
A42763 | 33545720 | Planta Med | Bioaccessibility and Absorption of Flavonoid C-glycosides from Abrus mollis Using Simulated Digestion, Caco-2 Cell, and In Situ Single-pass Perfusion Models. | 2021 | Details |
A42768 | 33527946 | Food Funct | Uridine attenuates obesity, ameliorates hepatic lipid accumulation and modifies the gut microbiota composition in mice fed with a high-fat diet. | 2021 | Details |
A42780 | 33497712 | Metabolism | Role of the gut microbiota in type 2 diabetes and related diseases. | 2021 | Details |
A42806 | 33425000 | Evid Based Complement Alternat Med | Ulmus parvifolia Jacq. Exhibits Antiobesity Properties and Potentially Induces Browning of White Adipose Tissue. | 2020 | Details |
A42807 | 33421313 | Mol Nutr Food Res | Metabolism and Inflammation: New Synergies and Insights. | 2021 | Details |
A42808 | 33420415 | Nat Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease: another leap forward. | 2021 | Details |
A42878 | 33228942 | Pediatr Clin North Am | Pulmonary Manifestations of Gastrointestinal, Pancreatic, and Liver Diseases in Children. | 2021 | Details |
A42890 | 33188417 | J Nutr | Minor Changes in the Composition and Function of the Gut Microbiota During a 12-Week Whole Grain Wheat or Refined Wheat Intervention Correlate with Liver Fat in Overweight and Obese Adults. | 2021 | Details |
A42902 | 33159427 | Liver Int | Targeting pathobionts for the treatment of alcohol-associated liver disease. | 2020 | Details |
A42907 | 33142445 | Poult Sci | Maintaining intestinal structural integrity is a potential protective mechanism against inflammation in goose fatty liver. | 2020 | Details |
A42909 | 33140925 | Minerva Med | Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease. | 2020 | Details |
A42949 | 32988545 | Poult Sci | Research Note: Increase of bad bacteria and decrease of good bacteria in the gut of layers with vs. without hepatic steatosis. | 2020 | Details |
A42975 | 32914727 | Endocr Metab Immune Disord Drug Targets | Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine. | 2021 | Details |
A42980 | 32895142 | Nan Fang Yi Ke Da Xue Xue Bao | [Gut microbiota-an important contributor to liver diseases]. | 2020 | Details |
A43005 | 32832510 | Hepatobiliary Surg Nutr | Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease. | 2020 | Details |
A43017 | 32805206 | Lancet Gastroenterol Hepatol | Intestinal motility: a therapeutic target for NAFLD? | 2020 | Details |
A43025 | 32780879 | Hepatology | Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. | 2021 | Details |
A43034 | 32755308 | Am J Physiol Gastrointest Liver Physiol | Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism. | 2020 | Details |
A43035 | 32751062 | Int J Mol Sci | Consumption of Wild Rice (Zizania latifolia) Prevents Metabolic Associated Fatty Liver Disease through the Modulation of the Gut Microbiota in Mice Model. | 2020 | Details |
A43043 | 32714511 | Int J Obes Suppl | From obesity through gut microbiota to cardiovascular diseases: a dangerous journey. | 2020 | Details |
A43059 | 32680469 | BMC Gastroenterol | Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis. | 2020 | Details |
A43074 | 32624568 | Exp Mol Med | Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. | 2020 | Details |
A43173 | 32374328 | Biomater Sci | A versatile ultrafine and super-absorptive H+-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection. | 2020 | Details |
A43181 | 32356701 | Med Sci (Paris) | [Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target]. | 2020 | Details |
A43194 | 32335802 | Front Med | Biological properties and clinical applications of berberine. | 2020 | Details |
A43200 | 32318746 | J Mol Med (Berl) | Fructose metabolism by the guts cuts liver fat. | 2020 | Details |
A43204 | 32302525 | Gastroenterology | Nonalcoholic Fatty Liver Disease in 2020. | 2020 | Details |
A43208 | 32282399 | Eur J Gastroenterol Hepatol | Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort. | 2021 | Details |
A43214 | 32274349 | J Clin Transl Hepatol | Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease. | 2019 | Details |
A43218 | 32269328 | Nat Rev Gastroenterol Hepatol | Intestinal gluconeogenesis prevents hepatic steatosis. | 2020 | Details |
A43225 | 32247247 | J Trace Elem Med Biol | Epidemiology, risk factors across the spectrum of age-related metabolic diseases. | 2020 | Details |
A43276 | 32087105 | Am J Med | A Confusing Picture: Refractory Encephalopathy Complicating Nonalcoholic Steatohepatitis. | 2020 | Details |
A43319 | 31984784 | Am J Physiol Gastrointest Liver Physiol | Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. | 2020 | Details |
A43360 | 31909364 | J Obes Metab Syndr | Effect of Diet on the Gut Microbiota Associated with Obesity. | 2019 | Details |
A43374 | 33777267 | Prz Gastroenterol | Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients. | 2020 | Details |
A43401 | 31823334 | Probiotics Antimicrob Proteins | Therapeutic and Nutritional Effects of Synbiotic Yogurts in Children and Adults: a Clinical Review. | 2020 | Details |
A43426 | 31752528 | Exp Biol Med (Maywood) | Mixture of blackberry leaf and fruit extracts alleviates non-alcoholic steatosis, enhances intestinal integrity, and increases Lactobacillus and Akkermansia in rats. | 2019 | Details |
A43427 | 31740806 | Nat Rev Gastroenterol Hepatol | What's new in NAFLD pathogenesis, biomarkers and treatment? | 2020 | Details |
A43463 | 31657225 | Am J Physiol Gastrointest Liver Physiol | Role of gut microbiota in liver disease. | 2019 | Details |
A43488 | 31591781 | Aliment Pharmacol Ther | Letter: probiotics? Yes, but which ones? Authors' reply. | 2019 | Details |
A43489 | 31591768 | Aliment Pharmacol Ther | Letter: probiotics? Yes, but which ones? | 2019 | Details |
A43496 | 31584530 | J Cardiovasc Pharmacol | NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium. | 2019 | Details |
A43501 | 31576541 | Adv Exp Med Biol | Contributing Roles of CYP2E1 and Other Cytochrome P450 Isoforms in Alcohol-Related Tissue Injury and Carcinogenesis. | 2019 | Details |
A43503 | 31573550 | J Clin Invest | The gut microbiome and metabolic syndrome. | 2019 | Details |